Citron Research Report Is Out
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
The 'Short' Who Sank Valeant Stock - WSJ
Valeant stock plunges 51% as the drugmaker has 'its worst day ever -- so far' - Los Angeles Times
Valeant shares jump 6 percent after analyst says 'short thesis has been debunked'
Q&A with Safkhet's Fahmi Quadir: 'I love investigating frauds and making money at their expense''
Citron Short Valeant Again
Short seller who foresaw Valeant crash now betting Tesla next for a dramatic drop | Financial Post
Bids for Valeant subsidiary iNova fall short of expectations | The Australian
Fahmi Quadir Just Got Smoked Short Selling Wirecard
Valeant Plunges 30% After Short Seller Citron Research Makes Fraud Allegation
13点のInterview With Andrew Left Short Seller Behind Valeant Selloff On Enron Comparisonのストックフォト - Getty Images
Former Valeant CEO unloaded more shares than previously thought
What the Average Short Position in Valeant
Watch Valeant Short Seller Picks Next Target - Bloomberg
The 'Short' Who Sank Valeant Stock - WSJ
Valeant shares recoup losses after company rejects short seller report - MarketWatch
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
McKinsey's fingerprints are all over Valeant | Financial Times
Behind the Anti-fraud Takedowns by Short Seller Fahmi Quadir | HEC Paris
The short seller who bet big against Valeant has turned bullish on the company he helped bring down - The Globe and Mail
Dirty Money: Drug Short (Netflix) or documentarymania | Chegg.com
Netflix Dirty Money — An Interview With Erin Lee Carr
The rise and fall of Valeant Pharmaceuticals | CBC News
The Valeant Meltdown and Wall Street's Major Drug Problem | Vanity Fair
Dirty Money" Drug Short (TV Episode 2018) - IMDb
